Bellerophon Revenue and Competitors

Warren, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bellerophon's estimated annual revenue is currently $3.3M per year.(i)
  • Bellerophon's estimated revenue per employee is $155,000

Employee Data

  • Bellerophon has 21 Employees.(i)
  • Bellerophon grew their employee count by -51% last year.

Bellerophon's People

NameTitleEmail/Phone
1
VP, Business OperationsReveal Email/Phone
2
VP, Clinical Operations & AdministrationReveal Email/Phone
3
Associate Director, ContractsReveal Email/Phone
4
Assistant Manager, Regulatory Affairs, Pharmacovigilance and Quality AssuranceReveal Email/Phone
5
Finance & HR ManagerReveal Email/Phone
6
Sr. Program ManagerReveal Email/Phone
7
Clinical Operations AssistantReveal Email/Phone
8
Clinical Supply AdminstratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.7M918%N/AN/A
Add Company

What Is Bellerophon?

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bellerophon News

2022-04-13 - Bellerophon Therapeutics (BLPH) – Investment Analysts ...

Bellerophon Therapeutics (NASDAQ: BLPH) has recently received a number of price target changes and ratings updates: 4/19/2022 – Bellerophon...

2022-04-13 - StockNews.com Initiates Coverage on Bellerophon ...

Other equities analysts have also recently issued research reports about the company. Zacks Investment Research cut Bellerophon Therapeutics...

2022-03-22 - Bellerophon Provides Clinical Program Update and Reports ...

WARREN, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M210%N/A
#2
$1.7M21-9%N/A
#3
$3.1M2222%N/A
#4
$5.1M2229%N/A
#5
$2.3M23N/AN/A